Retrospective Evaluation of the Incidence and Treatment of Cervical Cancer

Abstract

The second leading cause of death in women worldwide is cervical cancer, an important public health issue. The aim of the paper was to evaluate the prevalence of cervical neoplasia and the treatment used for this pathology. We included a total of 111 cases diagnosed with cervical neoplasia. Cervical cancers are found more frequently in women in perimenopause and menopause. In our study, stage I or carcinoma in situ was treated by conization or hysterectomy. The type of interventions for the other stages (I B, II A, and II B) was a radical hysterectomy and bilateral adnexectomy. In 79 (71.17%) cases the intervention was a radical Wertheim hysterectomy (with pelvic lymphadenectomy). We also identified 3 (2.70%) cases of stage IIIA, IIIB, or IV where it was performed an exploratory laparotomy. Cervical cancer can be detected relatively easily by screening, indicated especially in women at high risk, through a gynecological examination, vaginal cytology, and HPV genotyping. The prognosis is favorable in cases detected in the early stages and unfavorable in the advanced ones, so, it is dependent on the breakthrough stage, the woman's age, histopathological form, and the combination of therapeutic approaches to the task.